ABIONYX Pharma SA (FRA:609)
3.265
+0.150 (4.82%)
At close: Dec 19, 2025
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €122.58 million as of December 22, 2025. Its market cap has increased by 173.18% in one year.
Market Cap
122.58M
Enterprise Value
123.33M
Revenue
4.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.27
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 122.58M, a decrease of -42.76%. That is a compound annual growth rate of -5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 122.58M | 197.06% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | 24.29M | 229.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |